Orexigen (OREX) Higher Again, Shares Now Up ~90% in June Following Arena (ARNA), Analyst Upgrade
Get Alerts OREX Hot Sheet
Join SI Premium – FREE
Investors just can't get enough Orexigen Therapeutics (Nasdaq: OREX) following the FDA decision on Arena Pharmaceutircals (Nasdaq: ARNA) lorcaserin Wednesday and JPMorgan upgrade Thursday. Shares are up an additional 7.6 percent Friday, pushing shares up about 90 percent for the month of June.
Stock volatility is up about 2 percent from Thursday's close.
Stock volatility is up about 2 percent from Thursday's close.
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share